Helicobacter pylori vacA d1/-i1 genotypes and geographic differentiation between high and low incidence areas of gastric cancer in Iran

Archives of Iranian Medicine

Volumn 16, Issue 6, 2013, Pages 330-337

  Latifi Navid, Saeid ^a   Mohammadi, Shiva ^a   Maleki, Parichehr ^a   Zahri, Saber ^a   Yazdanbod, Abbas ^b   Siavoshi, Farideh ^c   Massarrat, Sadegh ^d  

^a UNIVERSITY OF MOHAGHEGH ARDABILI   (Iran)

^b ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gastric cancer; Genotypes; H. pylori; Incidence; Iran

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BABA2 GENE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CAGA GENE; CANCER INCIDENCE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; GEOGRAPHIC DISTRIBUTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; ICEA1 GENE; ICEA1/2 GENE; IRAN; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PREVALENCE; STOMACH CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84878855634     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. NEngl JMed 1991; 325: 1127-1131.
2. Wroblewski LE, Peek RM, Jr., Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010; 23: 713-739.
3. Peek RM, Jr., Fiske C, Wilson KT. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev. 2010; 90: 831-858.
4. Chen Y, Segers S, Blaser MJ. Association between Helicobacter pylori and mortality in the NHANES III study. Gut 2013 Jan 16. [Epub ahead of print]
5. Cover TL, Tummuru MK, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J BiolChem. 1994; 269: 10566-10573.
6. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, et al. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology. 2007; 133: 926-936.
7. Jones KR, Jang S, Chang JY Kim J, Chung IS, Olsen CH, et al. Polymorphisms in the intermediate region of VacA impact Helicobacter pylori-induced disease development. J Clin Microbiol. 2010; 49: 101-110.
8. Ogiwara H, Sugimoto M, Ohno T, Vilaichone RK, Mahachai V, Graham DY, et al. Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol. 2009; 47: 3493-500.
9. Jones KR, Joo YM, Jang S, Yoo YJ, Lee HS, Chung IS, et al. Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J Clin Microbiol. 2009; 47: 959-968.
10. Palli D, Masala G, Del Giudice G, Plebani M, Basso D, Berti D, et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2007; 120: 859-867.
11. van Doorn LJ, Figueiredo C, Sanna R Plaisier A, Schneeberger P, de Boer W, et al. Clinical relevance of the cagA vacA, and iceA status of Helicobacter pylori. Gastroenterology. 1998; 115: 58-66.
12. Shiota S, Watada M, Matsunari O, Iwatani S, Suzuki R Yamaoka Y Helicobacter pylori iceA, clinical outcomes, and correlation with cagA: a meta-analysis. PLoS One. 2012; 7: e30354.
13. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science. 1998; 279: 373-377.
14. Con SA, Takeuchi H, Nishioka M, Morimoto N, Sugiura T, Yasuda N, et al. Clinical relevance of Helicobacter pylori babA2 and babA2/B in Costa Rica and Japan. WorldJGastroenterol. 2010; 16: 474-478.
15. Talebi Bezmin Abadi A, Taghvaei T, Mohabbati Mobarez A, Vaira G, Vaira D. High correlation of babA (2)-positive strains of Helicobacter pylori with the presence of gastric cancer. Intern Emerg Med. 2011 May 22. [Epub ahead of print]
16. Malekzadeh R Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med2009; 12: 576-583.
17. Mousavis M, Gouya MM, Ramazani R Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009; 20: 556-563.
18. The-EUROGAST-Study-Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet. 1993; 341: 1359-1362.
19. Nouraie M, Latifi-Navid S, Rezvan H, Radmard AR Maghsudlu M, Zaer-Rezaii H, et al. Childhood hygienic practice and family education status determine the prevalence of Helicobacter pylori infection in Iran. Helicobacter. 2009; 14: 40-46.
20. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004; 57: 37-42.
21. Sadjadi A, Malekzadeh R Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer. 2003; 107: 113-118.
22. Babaei M, Pourfarzi F, Yazdanbod A, Chiniforush MM, Derakhshan MH, Mousavi SM, et al. Gastric cancer in Ardabil, Iran--a review and update on cancer registry data. Asian Pac J Cancer Prev. 2010; 11: 595-599.
23. Fallah M. Cancer Incidence in Five Provinces of Iran; Ardebil, Gilan, Mazandaran, Golestan, and Kerman. 1996-2000. Tampere: University of Tampere; 2007.
24. Eskanir H, Hossein SS, Rahim M, Jalal H, Mehrdad A, Rajabi T. Clinical profile of gastric cancer in Khuzestan, southwest of Iran. World J Gastroenterol. 2006; 12: 4832-4835.
25. Mohebbi M, Mahmoodi M, Wolfe R, Nourijelyani K, Mohammad K, Zeraati H, et al. Geographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data. BMC Cancer. 2008; 8: 137.
26. Latifi-Navid S, Ghorashi SA, Siavoshi F, Linz B, Massarrat S, Khegay T, et al. Ethnic and geographic differentiation ofHelicobacter pylori within Iran. PLoS One. 2010; 5: e9645.
27. de Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, Chaturvedi R et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut. 2011; 60: 1189-1195.
28. Lu Y, Redlinger TE, Avitia R, Galindo A, Goodman K. Isolation and genotyping of Helicobacter pylori from untreated municipal wastewater. ApplEnviron Microbiol. 2002; 68: 1436-1439.
29. Peakall R Smouse PE. GENALEX 6: Genetic analysis in Excel, population genetic software for teaching and research. Mol Ecol Notes. 2006; 6: 288-295.
30. Mantel N. The detection of disease clustering and a generalized regression approach. Cancer Res. 1967; 27: 209-220.
31. Gonzalez CA, Figueiredo C, Lic CB, Ferreira RM, Pardo ML, Ruiz Liso JM, et al. Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. Am J Gastroenterol. 2011; 106: 867-874.
32. Hussein NR, Mohammadi M, Talebkhan Y, Doraghi M, Letley DP, Muhammad MK, et al. Differences in virulence markers between Helicobacter pylori strains from Iraq and those from Iran: potential importance of regional differences in H. pylori-associated disease. J Clin Microbiol. 2008; 46: 1774-1779.
33. Jafari F, Shokrzadeh L, Dabiri H, Baghaei K, Yamaoka Y, Zojaji H, et al. vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis. 2008; 61: 290-293.
34. Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi AR, Saberifiroozi M. Association of H. pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol. 2006; 12: 5205-5210.
35. Mohammadi M, Oghalaie A, Mohajerani N, Massarrat S, Nasiri M, Bennedsen M, et al. Prevalence ofHelicobacter pylori vacuolating cytotoxin and its allelic mosaicism as a predictive marker for Iranian dyspeptic patients. BullSoc PatholExot. 2003; 96: 3-5.
36. Siavoshi F, Asgharzadeh A, Ghadiri H, Massarrat S, Latifi-Navid S, Zamani M. Helicobacter pylori genotypes and types of gastritis in first-degree relatives of gastric cancer patients. Int J Med Microbiol. 2011; 301: 506-512.
37. Douraghi M, Talebkhan Y, Zeraati H, Ebrahimzadeh F, Nahvijoo A, Morakabati A, et al. Multiple gene status in Helicobacter pylori strains and risk of gastric cancer development. Digestion. 2009; 80: 200-207.
38. Peek RM Jr., Thompson SA, Donahue IP, Tham KT, Atherton JC, Blaser MJ, et al. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA that is associated with clinical outcome. Proc Assoc Am Physicians. 1998; 110: 531-544.
39. Figueiredo C, Quint WG, Sanna R Sablon E, Donahue JP, Xu Q, et al. Genetic organization and heterogeneity of the iceA locus ofHelicobacter pylori. Gene. 2000; 246: 59-68.
40. Boyanova L, Yordanov D, Gergova G, Markovska R, Mitov I. Association of iceA and babA genotypes in Helicobacter pylori strains with patient and strain characteristics. Antonie Van Leeuwenhoek. 2010; 98: 343-350.
41. Gonzalez-Vazquez R Herrera-Gonzalez S, Cordova-Espinoza MG, Zuniga G, Giono-Cerezo S, Hernandez-Hernandez JM, et al. Helicobacter pylori: detection of iceA1 and iceA2 genes in the same strain in Mexican isolates. Arch Med Res. 2012; 43: 339-346.
42. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R Schepp W, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A. 1999; 96: 12778-12783.
43. Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol. 2003; 56: 287-291.
44. Lai CH, Kuo CH, Chen YC, Chao FY Poon SK, Chang CS, et al. High prevalence of cagA-and babA2-positiveHelicobacter pylori clinical isolates in Taiwan. J Clin Microbiol. 2002; 40: 3860-3862.
45. Kim SY, Woo CW, Lee YM, Son BR, Kim JW, Chae HB, et al. Genotyping CagA, VacA subtype, IceA1, and BabA of Helicobacter pylori isolates from Korean patients, and their association with gastroduodenal diseases. J Korean Med Sci. 2001; 16: 579-584.
46. Podzorski RP, Podzorski DS, Wuerth A, Tolia V. Analysis of the vacA, cagA, cagE, iceA, and babA2 genes in Helicobacter pylori from sixty-one pediatric patients from the Midwestern United States. Diagn Microbiol Infect Dis. 2003; 46: 83-88.
47. Atherton JC, Cao P, Peek RM Jr., Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995; 270: 17771-17777.
48. Achtman M, Azuma T, Berg DE, Ito Y Morelli G, Pan ZJ, et al. Recombination and clonal groupings within Helicobacter pylori from different geographical regions. Mol Microbiol. 1999; 32: 459-470.
49. Sicinschi LA, Correa P, Peek RM, Camargo MC, Piazuelo MB, Romero-Gallo J, et al. CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Micro biol Infect. 2009; 16: 369-378.
50. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999; 37:2274-2279.